Invitation to Revenio Group Corporation’s audiocast and conference call

Revenio Group Corporation’s January-June 2022 Half Year Financial Report will be published on Thursday, August 4, 2022, approximately at 09.00 a.m. (EEST). The report will be available at https://www.reveniogroup.fi/en/investors/reports_and_presentations

An audiocast and conference call for analysts and investors will be held in English at 3.00 p.m. (EEST) on the same day.

Link to the event: https://revenio.videosync.fi/results-q2-2022/

Dial in numbers for the conference call:
Finland: +358 9 8171 0310
Sweden: +46 8 5664 2651
United Kingdom: +44 33 3300 0804
United States: +1 63 1913 1422

PIN: 52423554#

For further information, please contact
Robin Pulkkinen, CFO, tel. +358 50 505 9932
[email protected]

Distribution
Key media
www.reveniogroup.fi/en

Revenio Group in brief
Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio’s ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.

In 2021, the Group’s net sales totaled EUR 78.8 million, with an operating profit of EUR 22.1 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.